CSIMarket

Announcement

Franklin Resources Under Scrutiny Investigations into Potential Securities Misconduct May Impact Investors

November 28, 2024

In a significant development that may reverberate through the financial markets, Franklin Resources, Inc. (NYSE: BEN) finds itself embroiled in ongoing investigations that have raised concerns among its shareholder community. Both the Rosen Law Firm and Berger Montague have launched inquiries into the company’s bu...

Business Update

QIAGEN Expands QIAstat-Dx Operations in Barcelona to Enhance Infectious Disease Testing Amid Revenue Challenges

November 28, 2024

In a strategic move to bolster its standing in the infectious diseases and precision medicine sectors, QIAGEN N.V. has announced plans to relocate its QIAstat-Dx operations to a newly established facility in Esplugues de Llobregat, near Barcelona. This initiative, part of a long-term investment strategy, aims to enh...

Product Service News

HUTCHMED Continues to Strengthen Its Portfolio with Key Drug Approvals and Renewals Amid Strategic Revisions in China

November 28, 2024

HUTCHMED (China) Limited has made significant strides in bolstering its pharmaceutical portfolio with the recent announcement regarding the continued inclusion of its innovative drug, ORPATHYS (savolitinib), in China s National Reimbursement Drug List (NRDL). Following a successful contract renewal with the China Na...

Stocks on the Move

Ameriprise Financial Inc. Navigating Market Trends and Earnings Stability Amid Mixed Analyst Sentiments

November 29, 2024

In the ever-evolving landscape of financial services, Ameriprise Financial Inc. (NYSE: AMP) has recently captured investor attention as a prominent player, demonstrating impressive market resilience amid mixed analyst sentiments and economic uncertainties. As of July 25, 2024, the company has seen a remarkable upt...

Stocks on the Move

Market Dynamics Analyzing Recent Performance and Analyst Reactions for Vislink Technologies, Inc. (NASDAQVISL)

November 29, 2024

In the ever-evolving landscape of investment opportunities, Vislink Technologies, Inc. (NASDAQ:VISL) has recently become a focal point for analysts and investors alike, following a series of noteworthy developments regarding its financial performance and market position. The narratives of the company s Q3 2024 finan...

Our most Popular Articles
Business Update

Blending Paths How Blend Labs and Prove Identity are Revamping Digital Onboarding

April 4, 2025

In the heart of San Francisco s bustling tech landscape, a new synergy is emerging that promises to reshape the world of digital banking. Blend Labs, Inc. (NYSE: BLND), a vanguard in crafting digital banking solutions, is partnering with Prove Identity, Inc. a powerhouse in digital identity verification. Together, t...

Announcement

“Ardelyx, Inc. Faces Investor Scrutiny Amid Financial Losses A Call to Action as Class Action Deadline Approaches

September 16, 2024

Ardelyx, Inc. a biopharmaceutical company specializing in the development of innovative therapies for patients with gastrointestinal and kidney conditions, is currently navigating turbulent waters. Recent reports have highlighted significant financial challenges while also announcing a key deadline for investors inv...

Clinical Study

Ardelyx to Present Promising OPTIMIZE Study Findings of XPHOZAH (Tenapanor) at National Kidney Foundation Spring Cl...

April 1, 2025

WALTHAM, Mass. March 31, 2025 Ardelyx, Inc. (Nasdaq: ARDX), a pioneering biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative first-in-class medicines, has exciting news to share with the medical community. An abstract highlighting a post-hoc analysis of the OPTIM...

Company News
Business Update

QIAGEN Expands QIAstat-Dx Operations in Barcelona to Enhance Infectious Disease Testing Amid Revenue Challenges

November 28, 2024

In a strategic move to bolster its standing in the infectious diseases and precision medicine sectors, QIAGEN N.V. has announced plans to relocate its QIAstat-Dx operations to a newly established facility in Esplugues de Llobregat, near Barcelona. This initiative, part of a long-term investment strategy, aims to enh...

Product Service News

HUTCHMED Continues to Strengthen Its Portfolio with Key Drug Approvals and Renewals Amid Strategic Revisions in China

November 28, 2024

HUTCHMED (China) Limited has made significant strides in bolstering its pharmaceutical portfolio with the recent announcement regarding the continued inclusion of its innovative drug, ORPATHYS (savolitinib), in China s National Reimbursement Drug List (NRDL). Following a successful contract renewal with the China Na...

Announcement

GXO Logistics Marks Milestones with Strategic Partnerships and Upcoming Earnings Call

November 28, 2024

Strategic Partnerships and Future Outlook: A Milestone for GXO Logistics, Inc.GXO Logistics, Inc. continues to solidify its position as a leader in the logistics sector, marking a noteworthy milestone with the recent contract renewal with OBI, a celebration of their five-year partnership. This renewal is a testamen...

Company News
Business Update

Zai Lab Secures Inclusion of AUGTYRO in China’s National Reimbursement Drug List, Announces Upcoming Presenta...

November 28, 2024
Company News
Business Update

Medicare Greenlights Nateras Prospera Lung Test Amidst R&D Recognition and Extensive Signatera Publications...

November 28, 2024
Company News
Business Update

Post-Election Surge Redfin Reports Significant Rise in Pending Home Sales as Buyer Demand Intensifies

November 28, 2024
More Company News
Business Update

Driving Forward Blue Bird and Micro Birds New York Manufacturing Leap Amidst Market Fluctuations,

November 28, 2024
Business Update

PJT Partners Charting Future Success at Goldman Sachs Financial Forum,

November 28, 2024
Management Announcement

ASP Isotopes Inc. Faces Scrutiny Amid Short Seller Allegations and Financial Struggles

November 28, 2024
Management Announcement

“VCI Global Soars Back into Nasdaq Compliance with Stellar ROA and a $24 Million AI Project: A New Chapter in Tech Innovation,

November 28, 2024
Management Announcement

Innovating for Safety: TOMI Environmental Solutions Makes Strides in Education and Financial Growth

November 28, 2024
Product Service News

Voyager Therapeutics Advances Tau Silencing Gene Therapy Candidate for Alzheimers Disease

November 28, 2024
Business Update

Tutor Perinis Strategic Debt Paydown Bolsters Financial Strength and Market Performance

November 28, 2024
Product Service News

Radwares AI-Powered DDoS Protection Sees Adoption by Major University Amidst Financial Turmoil

November 28, 2024
Business Update

Interactive Brokers Enhances European Footprint with Launch of Tax-Advantaged French Investment Accounts,

November 28, 2024
Business Update

Pfizers HYMPAVZI (Marstacimab) A Milestone in Hemophilia Treatment Amid Global Approvals

November 28, 2024
Related News
Business Update

Navigating the Dual Narratives of ACI Worldwide Growth and APP Scam Challenges

Announcement

Emerging Trends in Mining and Semiconductor Sectors Insights from Plato Gold and STMicroelectronics

Stocks
Business Update

TVA Partners with Brookfield and Argo in Historic Power Purchase Agreement Amidst Industry Shifts

Business Update

Seagate to Participate in Upcoming Investor Events

Business Update

Infinite Acquisitions Partners Enters LOI to Acquire Oceaneering Entertainment Systems and Partners with Falcons Beyond

Business News
Stocks on the Move

Ameriprise Financial Inc. Navigating Market Trends and Earnings Stability Amid Mixed Analyst Sentiments

In the ever-evolving landscape of financial services, Ameriprise Financial Inc. (NYSE: AMP) has recently captured investor attention as a prominent player, demonstrating impressive market resilience amid mixed analyst sentiments and economic uncertainties. As of July 25, 2024, the company has seen a remarkable upt...

Stocks on the Move

Market Dynamics Analyzing Recent Performance and Analyst Reactions for Vislink Technologies, Inc. (NASDAQVISL)

In the ever-evolving landscape of investment opportunities, Vislink Technologies, Inc. (NASDAQ:VISL) has recently become a focal point for analysts and investors alike, following a series of noteworthy developments regarding its financial performance and market position. The narratives of the company s Q3 2024 finan...

Business Update

QIAGEN Unveils Ambitious Expansion in Barcelona Pioneering the Future of Infectious Disease and Precision Medicine Te...

QIAGEN Expands QIAstat-Dx Operations with New Advanced Facility in Barcelona to Propel Infectious Diseases and Precision Medicine Testing In a bold step to bolster its global presence in the cutting-edge realms of infectious diseases and precision medicine testing, QIAGEN has announced a remarkable expansion of its ...

Announcement

New York, Nov. 28, 2024 In a significant development that could shape the legal and financial landscap...

Legal Turbulence Ahead: Rentokil Initial Plc Faces Robust Class Action Initiative New York, Nov. 28, 2024 In a significant development that could shape the legal and financial landscape of international pest control giant Rentokil Initial Plc, prominent law firm Bronstein, Gewirtz & Grossman, LLC has announced t...

Announcement

Franklin Resources Under Scrutiny Investigations into Potential Securities Misconduct May Impact Investors

In a significant development that may reverberate through the financial markets, Franklin Resources, Inc. (NYSE: BEN) finds itself embroiled in ongoing investigations that have raised concerns among its shareholder community. Both the Rosen Law Firm and Berger Montague have launched inquiries into the company’s bu...

Our Most Popular Articles
Business Update

Blending Paths How Blend Labs and Prove Identity are Revamping Digital Onboarding

In the heart of San Francisco s bustling tech landscape, a new synergy is emerging that promises to reshape the world of digital banking. Blend Labs, Inc. (NYSE: BLND), a vanguard in crafting digital banking solutions, is partnering with Prove Identity, Inc. a powerhouse in digital identity verification. Together, t...

Announcement

“Ardelyx, Inc. Faces Investor Scrutiny Amid Financial Losses A Call to Action as Class Action Deadline Approaches

Ardelyx, Inc. a biopharmaceutical company specializing in the development of innovative therapies for patients with gastrointestinal and kidney conditions, is currently navigating turbulent waters. Recent reports have highlighted significant financial challenges while also announcing a key deadline for investors inv...

Clinical Study

Ardelyx to Present Promising OPTIMIZE Study Findings of XPHOZAH (Tenapanor) at National Kidney Foundation Spring Cl...

WALTHAM, Mass. March 31, 2025 Ardelyx, Inc. (Nasdaq: ARDX), a pioneering biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative first-in-class medicines, has exciting news to share with the medical community. An abstract highlighting a post-hoc analysis of the OPTIM...

More News
Business Update

QIAGEN Expands QIAstat-Dx Operations in Barcelona to Enhance Infectious Disease Testing Amid Revenue Challenges

In a strategic move to bolster its standing in the infectious diseases and precision medicine sectors, QIAGEN N.V. has announced plans to relocate its QIAstat-Dx operations to a newly established facility in Esplugues de Llobregat, near Barcelona. This initiative, part of a long-term investment strategy, aims to enh...

Product Service News

HUTCHMED Continues to Strengthen Its Portfolio with Key Drug Approvals and Renewals Amid Strategic Revisions in China

HUTCHMED (China) Limited has made significant strides in bolstering its pharmaceutical portfolio with the recent announcement regarding the continued inclusion of its innovative drug, ORPATHYS (savolitinib), in China s National Reimbursement Drug List (NRDL). Following a successful contract renewal with the China Na...

Announcement

GXO Logistics Marks Milestones with Strategic Partnerships and Upcoming Earnings Call

Strategic Partnerships and Future Outlook: A Milestone for GXO Logistics, Inc.GXO Logistics, Inc. continues to solidify its position as a leader in the logistics sector, marking a noteworthy milestone with the recent contract renewal with OBI, a celebration of their five-year partnership. This renewal is a testamen...

Business Update

Zai Lab Secures Inclusion of AUGTYRO in China’s National Reimbursement Drug List, Announces Upcoming Presenta...

In a significant advancement for both healthcare access and cancer treatment in China, Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) announced the inclusion of AUGTYRO (repotrectinib) in the recently updated National Reimbursement Drug List (NRDL). The announcement, made in Shanghai and Cambridge, marks a crucial step ...

Business Update

Medicare Greenlights Nateras Prospera Lung Test Amidst R&D Recognition and Extensive Signatera Publications...

Natera Inc. a leading entity in the realm of cell-free DNA and genetic testing, has achieved another significant breakthrough as its Prospera Lung test has obtained Medicare coverage under the Centers for Medicare & Medicaid Services (CMS) Molecular Diagnostics Services (MolDX) Program. This development marks a subs...

Business Update

Post-Election Surge Redfin Reports Significant Rise in Pending Home Sales as Buyer Demand Intensifies

In a notable shift within the real estate market, pending home sales across the United States saw a remarkable rise of 12.1% year over year during the four-week period ending November 24, marking the most substantial increase since May 2021. This surge, as reported by Redfin, the technology-driven real estate broker...

Business Update

Driving Forward Blue Bird and Micro Birds New York Manufacturing Leap Amidst Market Fluctuations,

Blue Bird s New Horizon: Micro Bird Joint Venture to Establish Bus Manufacturing Facility in New York State Blue Bird Corporation, well-regarded for its commitment to innovation and quality in the commercial vehicle industry, has announced a prominent step forward. Through its joint venture, Micro Bird, Blue Bird is...

Business Update

PJT Partners Charting Future Success at Goldman Sachs Financial Forum,

PJT Partners Inc.: Ready to Take Center Stage at the Goldman Sachs 2024 Financial Services ConferenceIn an eagerly anticipated event on the financial calendar, PJT Partners Inc. is set to showcase its strategic vision and market insights at the Goldman Sachs 2024 Financial Services Conference. Scheduled for Decembe...

Management Announcement

ASP Isotopes Inc. Faces Scrutiny Amid Short Seller Allegations and Financial Struggles

In a recent disclosure, ASP Isotopes Inc. (NASDAQ: ASPI) responded to a short seller report released by Fuzzy Panda Research on November 26, 2024, that has raised eyebrows among investors and analysts alike. The company, which operates in the advanced materials sector with a focus on isotope production for various i...

Management Announcement

“VCI Global Soars Back into Nasdaq Compliance with Stellar ROA and a $24 Million AI Project: A New Chapter in Tech Innovation,

VCI Global s Resurgence: Compliance with Nasdaq, Impressive Returns, and a $24 Million AI ContractKuala Lumpur, Malaysia – November 26, 2024In a transformative day for stakeholders, VCI Global Limited (NASDAQ: VCIG) has officially regained compliance with the Nasdaq s minimum bid price requirement, signaling a cr...

Management Announcement

Innovating for Safety: TOMI Environmental Solutions Makes Strides in Education and Financial Growth

In a significant move underscoring the importance of health and safety in educational settings, Bonneville Joint School District No. 93 has integrated TOMI Environmental Solutions, Inc. s (NASDAQ: TOMZ) SteraMist technology into its cleaning protocols. This decision reflects the district’s commitment to prioritize...

Product Service News

Voyager Therapeutics Advances Tau Silencing Gene Therapy Candidate for Alzheimers Disease

Voyager Therapeutics, a prominent company in the field of gene therapy, has announced the selection of VY1706 as their lead candidate for a promising tau silencing gene therapy aimed at treating Alzheimer s disease. This decision marks a significant step forward in addressing one of the most challenging and prevalen...

Business Update

Tutor Perinis Strategic Debt Paydown Bolsters Financial Strength and Market Performance

In a significant move to fortify its financial standing, Tutor Perini Corporation (NYSE: TPC), a distinguished leader in the civil, building, and specialty construction sectors, has strategically reduced its debt by pre-paying an additional $100 million of its Term Loan B liability. This recent financial maneuver, coupled with a $50 million pre-payment announced in the company s earnings release on November 6, 2024, highlights Tutor Perini s commitment to strengthening its balance sheet. Altogether, the company has successfully deleveraged by $150 million over the past month, underscoring its robust financial strategy.As of this writing, Tutor Perini s share price stands at an impressive $28.36. The company’s shares have outperformed market expectations with a 4.71% increase during the current month, reflecting investor confidence in its prudent fiscal decisions. Over the past 12 months, Tutor Perini has consistently outpaced the market, establishing itself as a strong contender in the construction industry.

Product Service News

Radwares AI-Powered DDoS Protection Sees Adoption by Major University Amidst Financial Turmoil

In a climate increasingly hostile to digital security, Radware Ltd. has taken a significant step forward by providing its cloud-based Distributed Denial of Service (DDoS) protection to a top 10 higher education institution in the Midwestern United States. In an era where cyber threats loom larger than ever especiall...

Business Update

Interactive Brokers Enhances European Footprint with Launch of Tax-Advantaged French Investment Accounts,

Interactive Brokers (Nasdaq: IBKR), a leading global electronic brokerage firm, has announced a significant enhancement to its offerings with the introduction of Plan d’Epargne en Actions (PEA Classique) accounts. This strategic move marks the company’s commitment to broadening its services and tapping into the ...

Business Update

Pfizers HYMPAVZI (Marstacimab) A Milestone in Hemophilia Treatment Amid Global Approvals

Pfizer s HYMPAVZI (Marstacimab): A Milestone in Hemophilia Treatment Amid Global Approvals In a significant breakthrough for the management of severe hemophilia, Pfizer Inc. has garnered dual regulatory approvals for HYMPAVZI (marstacimab), marking a pivotal advancement in therapeutic options for patients suffering ...



Previous News 1. Page 174. Page 175. Page 176. Page .... 223. Page .... 273. Page NEXT 
Previous News


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.